Circio

Developer of immunotherapies for cancer treatment

placeOslo, Oslo, Norway calendar_todayFounded 2010 groups17 employees language circio.com

Registered entities

Social engagement

Social engagement: 5.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Private equity133%
Other / undisclosed267%

Recent activity

24 Jun 2026
Partnership
Tcelltech GmbH
10 Jun 2026
Event
Genetic Conversations panel discussion at ASGCT 2026
Coming soon